-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

311. Disorders of Platelet Number or Function: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, antibodies, apheresis, apoptosis, autoimmune disorders, Biological, Bleeding Disorders, Coronaviruses, Drug-induced thrombocytopenia, SARS-CoV-2/COVID-19, Animal models, bacterial, Bleeding and Clotting, Diseases, Hemostasis, Non-Biological, Combinations, Elderly, HIT, platelets, Therapies, Adverse Events, ITP, Biological Processes, Pregnancy, Immune Disorders, Platelet Disorders, Technology and Procedures, Cell Lineage, Infectious Diseases, Plasma Cell Disorders, Lymphoid Malignancies, Study Population, Clinically relevant, Thrombocytopenias, pharmacology, Quality Improvement , TTP, inflammation
Monday, December 7, 2020: 7:00 AM-3:30 PM

Rory McCulloch, FRCPath, MRCP, MBBS1*, Tom Bull, MBBS, FRCPath, MRCP2*, Phillip LR Nicolson, MA, MBBChir, MRCP3*, Rebecca J Shaw, MRCP4*, Zara Sayar, MD, FRCPath, MRCP5*, Alexander Langridge6*, Michala Pettitt, PhD7*, Rita Perry8*, David Tucker, MD9*, Marie Scully, MD10 and HaemSTAR Collaborators. (# joint first authors)11*

1Department of Haematology, University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
2Haematology Department, Cambridge University Hospitals, Cambridge, ENG, United Kingdom
3Institute for Cardiovascular Sciences, University of Birmingham, Birmingham, ENG, United Kingdom
4Royal Liverpool University Hospital, Liverpool, United Kingdom
5Haematology, Whittington Health NHS Trust, London, United Kingdom
6Haematology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom
7Birmingham Centre for Observational and Prospective Studies, Birmingham Surgical Trials Consortium, Birmingham, United Kingdom
8Institute of Applied Health Research, Birmingham Centre for Observational and Prospective Studies, Birmingham, United Kingdom
9Department of Haematology, Royal Cornwall Hospital, Truro, United Kingdom
10Department of Haematology, University College London Hospital, London, United Kingdom
11Haematology Specialty Trainees in Audit and Research (HaemSTAR) Network, Birmingham, United Kingdom

Nora V. Butta, PhD1*, María Teresa Alvarez Román, MD, PhD1*, Elena Monzón Manzano2*, Paula Acuña3*, Mónica Martín3*, María Isabel Rivas Pollmar3*, Raul Justo Sanz3*, Elena G Arias-Salgado, PhD4*, Sara García Barcenilla4*, Tamara Cebanu4*, Elena González Zorrilla4*, Miguel A Canales, MD, PhD1,5 and Victor Jimenez-Yuste, Medical Degree. PhD4,5*

1Hematology and Hemotherapy Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain
2Hospital Universitario La Paz-IdiPaz, Madrid, Spain
3Hospital Universitario La Paz-Idipaz, Madrid, Spain
4Hospital Universitario La Paz-IdiPAZ, Madrid, Spain
5Universidad Autónoma de Madrid, Madrid, Spain

Guillaume Moulis1*, Manuela Rueter, MSc2*, Margaux Lafaurie, PharmD, PhD student3* and Maryse Lapeyre-Mestre, MD, PhD2*

1Service de médecine interne, Toulouse University Hospital, Toulouse, France
2Toulouse University Hospital, Toulouse, France
3UMR 1027 - Inserm - University of Toulouse, Toulouse, France

Etienne Crickx1*, Guillaume Moulis2*, Marc Ruivard3*, Bouchra Asli4*, Jean Pierre Marolleau5, Mikael Ebbo6*, Etienne Riviere7*, Sylvain Audia8*, Louis Terriou9*, Marc Michel1*, Bertrand Godeau1* and Matthieu Mahevas10*

1Service de Médecine Interne, Centre national de référence des cytopénies auto-immunes de l’adulte, Hôpital Henri Mondor, 51 avenue du Maréchal de Lattre de Tassigny, Assistance Publique Hôpitaux de Paris, Université Paris Est Créteil, 94000 Créteil, Créteil, France
2Service de médecine interne, Toulouse University Hospital, Toulouse, France
3Service de médecine interne, CHU Estaing, Clermont-Ferrand, France
4Service de Médecine interne, C.H. Saint- Joseph et Saint-Luc, Lyon, France
5Hopital SUD, Amiens, Cedex 1, France
6Marseille Hospital, Marseille, France
7Service de médecine interne, Hôpital Haut-Lévêque, Bordeaux, France, Pessac, FRA
8CHU de Dijon, Dijon, France
9Hôpital Claude Huriez, Lille, France
10Service de Médecine Interne, Centre national de référence des cytopénies auto-immunes de l’adulte, Hôpital Henri Mondor, 51 avenue du Maréchal de Lattre de Tassigny, Assistance Publique Hôpitaux de Paris, Université Paris Est Créteil, 94000 Créteil, Creteil, France

Stephanie Guillet1*, Valentine Loustau2*, Anissa Zarour3*, Emmanuelle Boutin, MD4*, Thibault Comont5*, Nathalie Costedoat-Chalumeau, MD, PhD6*, Brigitte Pan-Petesch, MD7*, Delphine Gobert, M.D8*, Stephane Cheze, MD9*, Odile Souchaud-Debouverie10*, Jean-Francois Viallard11*, Anne-Sophie Morin12*, Gaetan Sauvetre13*, Manuel Cliquennois, MD, MSc14*, Bruno Royer, MD15*, Corinne Haioun, MD PhD16, Agathe Masseau17*, Louis Terriou18*, Claire Fieschi, MD, PhD19*, Matthieu Mahevas20*, Marc Michel21* and Bertrand Godeau21*

1Department of Internal Medecine, Henri Mondor University Hospital, Creteil, FRA
2Department of Internal Medecine, Henri Mondor University Hospital, Creteil, France
3Henri Mondor University Hospital, Creteil, France
4Department of Public Health and Biostatistics, Henri Mondor Hospital, Créteil, France
5Service de médecine interne, IUCT Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
6Department of Internal Medecine, Cochin University Hospital, Paris, FRA
7Haemophilia Treatment Centre, CHRU Brest, Brest, France
8Internal Medicine, Saint Antoine Hospital, Paris, France
9Service d'Hématologie Clinique, CHU Côte de Nacre, Caen, France
10Department of Internal Medecine, Miletrie University Hospital, Poitiers, France
11Haut-Leveque Hospital, Pessac, FRA
12Department of Internal Medicine, Bondy Hospital, Bondy, FRA
13Department of Internal Medecine, Charles-Nicolle University Hospital, Rouen, France
14Hôpital Saint Vincent De Paul, Lille Cedex, FRA
15Department of Immuno hematology, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Paris, France
16Clinical Hematology, Henri Mondor University Hospital, UPEC, Creteil, France
17Department of Internal Medecine, Hotel Dieu Hospital, Nantes, France
18Hôpital Claude Huriez, Lille, France
19Service d’Immunologie clinique, Hôpital Saint-Louis, AP-HP, Paris, France
20Service de Médecine Interne, Centre national de référence des cytopénies auto-immunes de l’adulte, Hôpital Henri Mondor, 51 avenue du Maréchal de Lattre de Tassigny, Assistance Publique Hôpitaux de Paris, Université Paris Est Créteil, 94000 Créteil, Creteil, France
21Service de Médecine Interne, Centre national de référence des cytopénies auto-immunes de l’adulte, Hôpital Henri Mondor, 51 avenue du Maréchal de Lattre de Tassigny, Assistance Publique Hôpitaux de Paris, Université Paris Est Créteil, 94000 Créteil, Créteil, France

Jia-Ning Zhang1*, Peng Zhao2*, Kaiyan Liu3, Ming Hou4*, Yanqiu Han, PhD5*, Jian-Da Hu, PhD6, Ze-Ping Zhou7*, Xin Wang, MD, PhD8, Ru Feng9*, Lin-Hua Yang, MD10*, He-Bing Zhou11*, Tie-nan Zhu, MD12*, Ye Jun Wu1* and Xiao-Hui Zhang13*

1Peking University People's Hospital, Beijing, China
2Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
3Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
4Qilu Hospital, Shandong University, Jinan, CHN
5The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Nei Mongol, CHN
6Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Union Hospital, Fujian Institute of Hematology, Fuzhou, China
7The Second Affiliated Hospital of Kunming Medical University, Kunming, CHN
8Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China
9Beijing Hospital, Beijing, CHN
10Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan, China
11Department of Hematology,Beijing Luhe Hospital,Capital Medical University, Beijing, China
12Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
13Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China, Beijing, China

Sameer Doshi1*, Zachary Jones1*, Ari Pritchard-Bell1*, Joseph Park1 and Per Olsson Gisleskog2*

1Amgen Inc, Thousand Oaks, CA
2POG Pharmacometrics Ltd, London, United Kingdom

Neelan Sriranjan, MD1*, Brett L. Houston, MD2, Emily Rimmer, MD, FRCPC2,3, Chantalle Menard, MD4*, Murdoch Leeies, MD5*, Allan Garland, MD5*, Ryan Zarychanski, MD, MSc, FRCPC2,6, Steve Doucette, MSc7* and Donald S. Houston, MD, PhD3

1Internal Medicine, University of Manitoba, Winnipeg, MB, Canada
2University of Manitoba / CancerCare Manitoba, Winnipeg, MB, Canada
3Section of Hematology and Medical Oncology, Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
4University of Manitoba, Winnipeg, MB, CAN
5University of Manitoba, Winnipeg, MB, Canada
6Cancercare Manitoba University of Manitoba, Winnipeg, MB, Canada
7Dalhousie University, Halifax, NS, Canada

James B. Bussel1, Waleed Ghanima2, Nichola Cooper, MD3, Alexandra Kruse4*, Caroline Kruse4*, Yoshiaki Tomiyama5, Ming Hou6, Cristina Santoro7*, Serge Laborde8*, Mervyn Morgan9*, Barbara Lovrencic10*, Tom Bailey, MSci11*, Jens Haenig12* and Drew Provan13*

1Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY
2Department of Medicine, Østfold Hospital Trust, Kalnes, Norway
3Hammersmith Hospital, Imperial College London, London, United Kingdom
4Platelet Disorder Support Association, Cleveland, OH
5Osaka University Hospital, Osaka, Japan
6Department of Hematology, Qilu Hospital of Shandong University, Jinan, China
7Hematology, University Hospital Policlinico Umberto I, Rome, Italy
8O’Cyto, Saint Loubès, France
9ITP Support Association, Bolnhurst, United Kingdom
10Italian Association for Immune Thrombocytopenic Purpura, Caprino Veronese, Italy
11Adelphi Real World, Bollington, United Kingdom
12Novartis Pharma AG, Basel, Switzerland
13Barts and The London School of Medicine and Dentistry, London, United Kingdom

Paul J. Hampel, MD1, David L. Murray, MD, PhD2*, Rajiv K. Pruthi, M.B.B.S1,3, Aishwarya Ravindran, MBBS4, Dong Chen, M.D., Ph.D.2 and Ronald S. Go, MD1,5

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
3Division of Hematopathology, Special Coagulation Laboratory, Mayo Clinic, Rochester, MN
4Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
5Mayo Clinic Rochester, Division of Hematology, Onalaska, WI

Surbhi Warrior, MD MPH1*, Elizabeth Behrens, MD1, Sefer Gezer, MD2,3, Parameswaran Venugopal, MD2,3 and Shivi Jain, MD, MBBS2,3

1Department of Internal Medicine, Rush University Medical Center, Chicago, IL
2Division of Hematology Oncology, Rush University Medical Center, Chicago, IL
3Rush University Cancer Center, Chicago, IL

Eun-Ju Lee, MD1, Madhav Seshadri, MD2* and James B. Bussel3

1Department of Medicine, NewYork-Presbyterian Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY
2Weill Cornell/New York-Presbyterian Hospital, New York, NY
3Department of Pediatrics, Division of Hematology, Weill Cornell Medicine, New York, NY

Jennifer Diraimo, MS, CCGC1*, Caroline Kruse1*, Michele P. Lambert, MD, MSTR2 and Alexandra Kruse1,3*

1Platelet Disorder Support Association, Cleveland, OH
2Department of Pediatrics, Division of Hematology, Children's Hosp. of Phila., Philadelphia, PA
3Tulane University School of Medicine, New Orleans, LA

Irene García García1*, Moraima Jiménez2*, David Valcárcel, MD, PhD3, Maria Eva Mingot-Castellano, PhD, MD4*, Maria Cristina Pascual Izquierdo, PhD, MD5*, Aurora Viejo, MD6*, Miquel Lozano7*, Rosa Goterris, MD8*, Jorge Martínez Nieto9*, Ana Oliva, MD10*, Inés Gómez-Seguí, PhMD11*, Luis Hernandez, MD12*, Saioa Zalba13*, Verónica Campuzano14*, Yolanda Martínez15*, Helena González16*, Inmaculada Tallon17*, Miguel Fernández Zarzoso18*, Gemma Moreno Jiménez, MD19*, Sunil Lakhwani Lakhwani20*, Sandra Ortega21*, María Solé22*, Jon Ander Atucha Fernández23*, Julio Del Rio-Garma, MD24* and Joan Cid, MD, PhD7*

1Hematology and Hemotherapy, Hospital Universitario Ramón y Cajal, Madrid, Spain
2Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain
3Hematology Department, Department of Hematology. Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron., Barcelona, Spain, Barcelona, Spain
4Hospital Universitario Virgen del Rocio, Sevilla, Spain
5Hematology, Hospital Universitario Gregorio Marañon, Madrid, Spain
6Transfusion Medicine, La Paz University Hospital-IdiPAZ, Madrid, Spain
7Hospital Clínic, Barcelona, Spain
8Hospital Clinico Universitario de Valencia, Valencia, Spain
9Hospital Clínico San Carlos, Madrid, Spain
10H Universitario V de la Candelaria, Tenerife, Spain
11Servicio de Hematología. Hospital La Fe, Valencia, Spain, Valencia, Spain
12Hospital General Universitario de Alicante, Alicante, Spain
13Complejo Hospitalario de Navarra, Pamplona, Spain
14Hospital Universitario de Burgos, Burgos, Spain
15Fundación Jiménez Díaz, Madrid, Spain
16Hospital General de Villalba, Villalba, Spain
17Hospital Virgen Macarena, Sevilla, Spain
18Hospital Universitario Dr. Peser, Valencia, Spain
19Hematology and Hemotherapy Department, Hospital Universitario Ramón y Cajal, Madrid, Spain
20Department of Hematology, Hospital Universitario de Canarias, La Laguna, La Laguna, Spain
21Hospital de Bellvitge, Banc de Sang i Teixits, L´Hospitalet de Llobregat, Spain
22Hospital Juan R. Jiménez, Huelva, Spain
23Hospital Universitario de Basurto Osakidetza, Basurto, Spain
24Hospital Universitario Orense, ORENSE, Spain

Rawan Hammoudeh, MBBS1, Yaser Alkhatib, MD2 and Qutaiba Sabha1*

1Department of Internal Medicine, Henry Ford Hospital/Wayne State University, Detroit, MI
2Division of Hematology and Oncology, Henry Ford Health System, Detroit, MI

Shivi Jain, MD, MBBS1, Matthew Wojdyla, PharmD2*, Michael Vredenburg, PhD2*, Brian Jamieson, MD, BA2 and Terry B. Gernsheimer, MD3

1Division of Hematology Oncology, Rush University Medical Center, Chicago, IL
2Dova Pharmaceuticals, Durham, NC
3Department of Medicine, Division of Hematology, University of Washington Medical Center, Seattle, WA

Seema S. Bhatwadekar, MD, MBBS1,2, Shubhangi Vishwas Deshpande, M.D3*, Shweta Vikas Khadse, BHMS4*, Devashri Jani, BHMS4*, Ujjwala Lakhmapurkar, BAMS4*, Pina Vasoya, BAMS4*, Saloni Shah, BHMS4*, Aangi Jayesh Shah, MBBS4*, Bijal Shah, MBBS, DCP5* and Devenkumar Desai, MBBS DCP6*

1Haemato-oncology Care Centre,, Vadodara, IND
2Bhailal Amin Hospital, Vadodara, India
3GMERS Medical College and Hospital Gotri, Vadodara, India
4Haemato Oncology Care Centre (HOCC), Vadodara, India
5Labcore Speciality Laboratory, Vadodara, India
6Lab core Speciality Lab, Vadodara, India

Michael D Tarantino, MD1, Michael Vredenburg, PhD2*, Wei Tian, PhD2*, Brian Jamieson, MD, BA2 and Kashyap B Patel, MD3*

1Bleeding & Clotting Disorders Institute, Peoria, IL
2Dova Pharmaceuticals, Durham, NC
3Carolina Blood and Cancer Care, Rock Hill, SC

*signifies non-member of ASH